Yourgene Health Plc, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. The company is headquartered in Manchester, the United Kingdom.
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone44 16 1667 6865
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£8.88 million
Profitability
Miscellaneous
Employees91
Next Earnings DateN/A
OptionableNot Optionable
Yourgene Health (LON:YGEN) Frequently Asked Questions
What is Yourgene Health's stock symbol?
Yourgene Health trades on the London Stock Exchange (LON) under the ticker symbol "YGEN."
Has Yourgene Health been receiving favorable news coverage?
Media coverage about YGEN stock has trended extremely negative recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Yourgene Health earned a coverage optimism score of -4.6 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Yourgene Health.
Who are some of Yourgene Health's key competitors?
Some companies that are related to Yourgene Health include Akumin (AKU), Senseonics (SENS), Palatin Technologies (PTN), Exagen (XGN), Renalytix Ai (RENX), Profound Medical (PRN), Oncosil Medical (OSL), BARD1 Life Sciences (BD1), MaxCyte (MXCT), Oncimmune (ONC), Sernova (SVA), Lexagene (LXG), SQI Diagnostics (SQD), GeneNews (GEN) and Deepmatter Group (DMTR).
What other stocks do shareholders of Yourgene Health own?
Who are Yourgene Health's key executives?
Yourgene Health's management team includes the folowing people:
- Dr. Stephen Little, Exec. Vice Chairman (Age 62)
- Mr. Barry Hextall, CFO, Sec. & Exec. Director
- Dr. Chia-Han Chan, Chief Scientific Officer & Director (Age 43)
- Mr. Lyn Fafydd Rees, CEO & Director (Age 46)
- Mr. Hayden Jeffreys, COO & Director (Age 44)
How do I buy shares of Yourgene Health?
Shares of YGEN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Yourgene Health's stock price today?
One share of YGEN stock can currently be purchased for approximately GBX 11.35.
How big of a company is Yourgene Health?
What is Yourgene Health's official website?
How can I contact Yourgene Health?
The company can be reached via phone at 44 16 1667 6865.
MarketBeat Community Rating for Yourgene Health (LON YGEN)
MarketBeat's community ratings are surveys of what our community members think about Yourgene Health and other stocks. Vote "Outperform" if you believe YGEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe YGEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
